Addenbrooke’s Charitable Trust (ACT) is to host a festive fundraiser with a difference on Thursday (4 December) in aid of the ...
Cross-trial analysis supports plasma pTau as a potential early predictor of clinical benefit, reinforcing the biomarker-driven design of ProMIS’ PRECISE-AD trial ProMIS on track to leverage new plasma ...
Tech Xplore on MSN
Weaving secondary battery electrodes with fibers and tying them like ropes for both durability and performance
A joint research team led by Dr. Gyujin Song of the Korea Institute of Energy Research (President: Yi, Chang-Keun, hereafter ...
Insilico Medicine (“Insilico”), a global leader in AI-powered drug discovery, and Atossa Therapeutics (“Atossa”) (Nasdaq: ...
inews.co.uk on MSN
My child was born with hundreds of tumours - a charity helped get better treatment
Rachael Young was born with tumours attached to every organ including her brain. Here's how Young Lives vs Cancer aided her ...
A Stevenage teenager diagnosed with a life-changing brain tumour has made it his mission to improve care for other young patients.
Insilico Medicine (“Insilico”), a global leader in AI-powered drug discovery, and Atossa Therapeutics (“Atossa”) ...
As a result, many common British sodas and packaged drinks now have significantly lower sugar levels than the identical ...
State Rep. Jim Murphy says the bill was prompted by The Independent’s story about a Nebraska veteran who gave 35 times this ...
Results support the potential of PMN310 to improve outcomes by selectively targeting oligomers and avoiding binding to monomer and plaque ProMIS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback